Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | CTSB | P07858 | 2/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30640783 | 1.00 | CASP3 (0.47) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL24580512 | 0.97 | CASP3 (0.45) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL29696636 | 0.89 | CASP3 (0.42) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL29697699 | 0.88 | CASP3 (0.47) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL24579473 | 0.88 | CASP3 (0.47) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL29696671 | 0.87 | CASP3 (0.51) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL23629983 | 0.87 | CASP3 (0.52) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL23629988 | 0.87 | CASP3 (0.52) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL23629985 | 0.87 | CASP3 (0.52) | CASP3KMT2ACTSLCTSBCTSS | |
| SCHEMBL29866548 | 0.87 | CASP3 (0.52) | CASP3KMT2ACTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022138891-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | 中外製薬株式会社 | 2022-06-30 | — | — | WO | disclosed |